Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2001 1
2009 1
2017 1
2018 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results. The following terms were ignored: %, % The following terms were not found in PubMed: 5BAuthor
Page 1
German Value Set for the EQ-5D-5L.
Ludwig K, Graf von der Schulenburg JM, Greiner W. Ludwig K, et al. Pharmacoeconomics. 2018 Jun;36(6):663-674. doi: 10.1007/s40273-018-0615-8. Pharmacoeconomics. 2018. PMID: 29460066 Free PMC article.
As the first country to do so, the study design used the improved EQ-5D-5L valuation protocol 2.0 developed by the EuroQol Group, including a feedback module as internal validation and a quality control process that was missing in the first wave of EQ-5D-5L valuatio …
As the first country to do so, the study design used the improved EQ-5D-5L valuation protocol 2.0 developed by the EuroQol Group, inc …
Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.
Ludwig K, von der Schulenburg JG, Greiner W. Ludwig K, et al. Health Qual Life Outcomes. 2017 Feb 20;15(1):39. doi: 10.1186/s12955-017-0617-9. Health Qual Life Outcomes. 2017. PMID: 28219389 Free PMC article.
BACKGROUND: The EuroQol Group has extended the severity levels of the EQ-5D from three to five (EQ-5D-5L). There are valuation studies worldwide planned in order to convert the EQ-5D-5L health states into a single preference-based summary score based on count …
BACKGROUND: The EuroQol Group has extended the severity levels of the EQ-5D from three to five (EQ-5D-5L). There are valuation …
High-dose treatment with (186)Re-HEDP or (153)Sm-EDTMP combined with amifostine in a rabbit model.
Brenner W, Kampen WU, von Forstner C, Brümmer C, Zuhayra M, Muhle C, Czech N, Henze E. Brenner W, et al. J Nucl Med. 2001 Oct;42(10):1545-50. J Nucl Med. 2001. PMID: 11585871 Free article.

RESULTS: For (186)Re-HEDP, the mean decrease in platelets was significantly less in the amifostine group (35.5% +/- 2.4%) than in the control group (61.3% +/- 5.4%, P < 0.001). Similar results were found for (153)Sm-EDTMP (36.5% +/- 8.3% vs. 52.3% +/- 14.0%, P &l

RESULTS: For (186)Re-HEDP, the mean decrease in platelets was significantly less in the amifostine group (35.5% +/- 2.4%) than in the contro …
Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.
Provenzano R, Schiller B, Rao M, Coyne D, Brenner L, Pereira BJ. Provenzano R, et al. Clin J Am Soc Nephrol. 2009 Feb;4(2):386-93. doi: 10.2215/CJN.02840608. Epub 2009 Jan 28. Clin J Am Soc Nephrol. 2009. PMID: 19176796 Free PMC article. Clinical Trial.
RESULTS: Ferumoxytol resulted in a mean increase in hemoglobin of 1.02 +/- 1.13 g/dl at day 35 compared with 0.46 +/- 1.06 g/dl with oral iron (P = 0.0002). Twice as many ferumoxytol-treated patients than oral iron-treated patients achieved a > or =1 g/dl hemoglobin inc …
RESULTS: Ferumoxytol resulted in a mean increase in hemoglobin of 1.02 +/- 1.13 g/dl at day 35 compared with 0.46 +/- 1.06 g/dl with oral ir …
Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
Brenner DM, Sayuk GS, Abel JL, Burslem K. Brenner DM, et al. J Manag Care Spec Pharm. 2021 Apr;27(4):469-477. J Manag Care Spec Pharm. 2021. PMID: 33769858
From baseline to week 12, compared with placebo, twice-daily treatment with eluxadoline resulted in significantly greater reductions in absenteeism (2.6%; P = 0.046). Numerically greater decreases in presenteeism, overall work productivity loss, and daily activity impairme …
From baseline to week 12, compared with placebo, twice-daily treatment with eluxadoline resulted in significantly greater reductions in abse …
Early enhancement of fluid transport in rabbit proximal straight tubules after loss of contralateral renal excretory function.
Tabei K, Levenson DJ, Brenner BM. Tabei K, et al. J Clin Invest. 1983 Sep;72(3):871-81. doi: 10.1172/JCI111058. J Clin Invest. 1983. PMID: 6886008 Free PMC article.
At 24 h, despite the absence of measurable hypertrophy of the contralateral (right) kidney, these procedures significantly increased p-aminohippurate clearance (45-54%) and inulin clearance (CIN) (64-110%) compared with sham-operated control animals. ...The increase in Jv …
At 24 h, despite the absence of measurable hypertrophy of the contralateral (right) kidney, these procedures significantly increased p